» Articles » PMID: 7437256

Propranolol LA and Ambulatory Blood Pressure

Overview
Specialty Pharmacology
Date 1980 Nov 1
PMID 7437256
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

1 The technique of continuous recording of intra-arterial blood pressure in ambulant hypertensives has been used to investigate the effects of a long-acting formulation of propranolol (propranolol LA). 2 Seven subjects with untreated essential hypertension were studied before and 2 months after commencing treatment with propranolol LA once daily in the morning, results showing that smooth control of blood pressure and heart rate occurred throughout 24 h. 3 Bicycle ergometry tests performed by these subjects during both studies showed significant blood pressure reduction by propranolol LA during the mild and moderate grades of dynamic exercise. 4 In a parallel study where six treated hypertensives were monitored before and after substitution of standard propranolol by the 'LA' form, close correspondence of blood pressure throughout the 24 h occurred with each regimen.

Citing Articles

The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man.

Koopmans R, Oosterhuis B, Karemaker J, Wemer J, van Boxtel C Eur J Clin Pharmacol. 1993; 44(2):171-6.

PMID: 8453962 DOI: 10.1007/BF00315476.


The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension.

Millar-Craig M, Mann S, Bala Subramanian V, Altman D, Raftery E Eur J Clin Pharmacol. 1983; 24(6):713-21.

PMID: 6884408 DOI: 10.1007/BF00607076.


Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.

Floras J, Jones J, Hassan M, Sleight P Br Med J (Clin Res Ed). 1982; 285(6352):1387-92.

PMID: 6814568 PMC: 1500409. DOI: 10.1136/bmj.285.6352.1387.


Pharmacokinetic and pharmacodynamic studies with a new controlled-release formulation of propranolol in normal volunteers: a comparison with other commercially available formulations.

Perucca E, Grimaldi R, Gatti G, Caravaggi M, Crema F, Lecchini S Br J Clin Pharmacol. 1984; 18(1):37-43.

PMID: 6743489 PMC: 1463571. DOI: 10.1111/j.1365-2125.1984.tb05019.x.


Comparison of propranolol and propranolol LA in hypertension using 24-hr noninvasive blood pressure monitoring.

Rustin M, COOMES E Postgrad Med J. 1983; 59(698):770-4.

PMID: 6686326 PMC: 2417800. DOI: 10.1136/pgmj.59.698.770.


References
1.
Reybrouck T, Amery A, Fagard R, Jousten P, Lijnen P, MEULEPAS E . Beta-blockers: once or three times a day?. Br Med J. 1978; 1(6124):1386-8. PMC: 1604739. DOI: 10.1136/bmj.1.6124.1386. View

2.
Mcainsh J, Baber N, Smith R, Young J . Pharmacokinetic and pharmacodynamic studies with long-acting propranolol. Br J Clin Pharmacol. 1978; 6(2):115-21. PMC: 1429409. DOI: 10.1111/j.1365-2125.1978.tb00835.x. View

3.
Millar Craig M, Mann S, Balasubramanian V, Raftery E . Blood pressure circadian rhythm in essential hypertension. Clin Sci Mol Med Suppl. 1978; 4:391s-393s. DOI: 10.1042/cs055391s. View

4.
Millar-Craig M, Hawes D, Whittington J . New system for recording ambulatory blood pressure in man. Med Biol Eng Comput. 1978; 16(6):727-31. DOI: 10.1007/BF02442453. View

5.
Craig M, Kenny D, Mann S, Balasubramanian V, Raftery E . Effect of once-daily atenolol on ambulatory blood pressure. Br Med J. 1979; 1(6158):237-8. PMC: 1597910. DOI: 10.1136/bmj.1.6158.237-a. View